NASDAQ:NXTM - Nasdaq - US67072V1035
30
+0.01 (+0.03%)
The current stock price of NXTM is 30 null. In the past month the price increased by 5.49%. In the past year, price increased by 27.71%.
NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.
NXSTAGE MEDICAL INC
350 MERRIMACK STREET
LAWRENCE MA 01843
CEO: Jeffrey H. Burbank
Phone: 978-687-4700
The current stock price of NXTM is 30 null. The price increased by 0.03% in the last trading session.
The exchange symbol of NXSTAGE MEDICAL INC is NXTM and it is listed on the Nasdaq exchange.
NXTM stock is listed on the Nasdaq exchange.
NXSTAGE MEDICAL INC (NXTM) has a market capitalization of 2.00B null. This makes NXTM a Mid Cap stock.
NXSTAGE MEDICAL INC (NXTM) has a support level at 29.39 and a resistance level at 30.01. Check the full technical report for a detailed analysis of NXTM support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NXTM does not pay a dividend.
NXSTAGE MEDICAL INC (NXTM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.08).
ChartMill assigns a technical rating of 9 / 10 to NXTM. When comparing the yearly performance of all stocks, NXTM is one of the better performing stocks in the market, outperforming 87.3% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to NXTM. Both the profitability and the financial health of NXTM get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months NXTM reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 61.9% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -1.29% | ||
ROA | -1.46% | ||
ROE | -2.44% | ||
Debt/Equity | 0 |